Joyce Liu, Md

This study tests a drug called azenosertib in 25 women with a rare and aggressive type of uterine cancer that has come back or not gone away. The goal is to see how the drug affects cancer cells and whether it can shrink tumors or slow the disease. Participants take the drug and …